Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 862

1.

A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M, Yamaguchi A, Deprez P, Mollat P, Murali R, Ohya K, Horne WC, Baron R.

J Clin Invest. 2006 Jun;116(6):1525-34. Epub 2006 May 4.

PMID:
16680194
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.

Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K.

J Clin Invest. 2006 Feb;116(2):528-35. Epub 2006 Jan 19.

PMID:
16424941
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo.

Cheng X, Kinosaki M, Takami M, Choi Y, Zhang H, Murali R.

J Biol Chem. 2004 Feb 27;279(9):8269-77. Epub 2003 Dec 15.

PMID:
14679212
[PubMed - indexed for MEDLINE]
Free Article
5.

Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.

Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H.

J Immunol. 2003 Nov 15;171(10):5130-9.

PMID:
14607912
[PubMed - indexed for MEDLINE]
Free Article
6.

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.

J Bone Miner Res. 2001 Oct;16(10):1787-94.

PMID:
11585342
[PubMed - indexed for MEDLINE]
7.

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.

Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y.

J Biol Chem. 2001 Jan 5;276(1):563-8.

PMID:
11032840
[PubMed - indexed for MEDLINE]
Free Article
8.

Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.

Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.

J Biol Chem. 2006 Feb 3;281(5):2414-29. Epub 2005 Oct 25.

PMID:
16251181
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.

Sugatani T, Alvarez UM, Hruska KA.

J Cell Biochem. 2003 Sep 1;90(1):59-67.

PMID:
12938156
[PubMed - indexed for MEDLINE]
11.

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.

Bone. 2005 Jan;36(1):159-72. Epub 2004 Nov 24.

PMID:
15664014
[PubMed - indexed for MEDLINE]
12.

Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.

Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.

J Immunol. 2005 Aug 1;175(3):1956-64.

PMID:
16034140
[PubMed - indexed for MEDLINE]
Free Article
13.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

PMID:
15824857
[PubMed - indexed for MEDLINE]
14.

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA.

J Bone Miner Res. 2001 Jun;16(6):1004-14.

PMID:
11393777
[PubMed - indexed for MEDLINE]
15.

Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.

Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.

J Endocrinol. 2005 Jun;185(3):401-13.

PMID:
15930166
[PubMed - indexed for MEDLINE]
Free Article
16.

Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism.

Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z.

J Cell Biochem. 2001 Jun 26-Jul 25;83(1):70-83.

PMID:
11500955
[PubMed - indexed for MEDLINE]
17.

Role of IGF-I signaling in regulating osteoclastogenesis.

Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD.

J Bone Miner Res. 2006 Sep;21(9):1350-8.

PMID:
16939393
[PubMed - indexed for MEDLINE]
19.

Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function.

Liu W, Xu D, Yang H, Xu H, Shi Z, Cao X, Takeshita S, Liu J, Teale M, Feng X.

J Biol Chem. 2004 Dec 24;279(52):54759-69. Epub 2004 Oct 12.

PMID:
15485878
[PubMed - indexed for MEDLINE]
Free Article
20.

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T.

J Biol Chem. 2003 Jun 27;278(26):23971-7. Epub 2003 Apr 15.

PMID:
12697767
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk